Fig. 6.

Course of a 20 year old woman who received a course of heterologous globulin therapy beginning 5 months after transplantation of a homograft from her mother. Previously, reductions in prednisone dosage led to slow rejection. As she was treated with antilymphocyte globulin, prednisone was reduced to 15 milligrams per day without incident. During the year since the completion of globulin therapy, her function has remained relatively stable at a prednisone dose of 15 milligrams per day. Her antigenic match with her donor was grade B. In this instance, the multiple early postoperative complications made any hope for survival dependent upon rapid reduction of the steroid quantities.